Nocardiosis in Kidney Transplant Recipients and Possible Association With Decreased Utilization of Trimethoprim/Sulfamethoxazole During COVID-19

Transplantation. 2024 Jul 1;108(7):e150-e151. doi: 10.1097/TP.0000000000004974. Epub 2024 Jun 21.

Authors

Affiliations

¹ Department of Pharmacy, Yale-New Haven Hospital, New Haven, CT.
² Department of Pharmacy, Montefiore Medical Center, Bronx, NY.
³ Department of Internal Medicine, Section of Nephrology, Yale School of Medicine, New Haven, CT.
⁴ Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT.

PMID: 38917242
DOI: 10.1097/TP.0000000000004974

No abstract available

Publication types

Letter

MeSH terms

Anti-Bacterial Agents / therapeutic use
COVID-19* / epidemiology
Female
Humans
Immunosuppressive Agents / adverse effects
Kidney Transplantation* / adverse effects
Male
Middle Aged
Nocardia Infections* / diagnosis
Nocardia Infections* / drug therapy
Nocardia Infections* / epidemiology
Nocardia Infections* / immunology
SARS-CoV-2
Transplant Recipients
Trimethoprim, Sulfamethoxazole Drug Combination* / therapeutic use

Substances

Trimethoprim, Sulfamethoxazole Drug Combination
Anti-Bacterial Agents
Immunosuppressive Agents